Eventide Asset Management, LLC Procept Bio Robotics Corp Transaction History
Eventide Asset Management, LLC
- $5.26 Billion
- Q2 2025
A detailed history of Eventide Asset Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 468,476 shares of PRCT stock, worth $16.1 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
468,476
Previous 351,962
33.1%
Holding current value
$16.1 Million
Previous $20.5 Million
31.6%
% of portfolio
0.51%
Previous 0.44%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$180 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$120 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.2 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$53.9 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$52.5 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.53B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...